Dipyridamole in the Management of Epstein-Barr Reactivation Syndrome
By Peter A. McCullough, MD, MPH With 75% of the population taking at least one COVID-19 vaccine and >94% of us having contracted COVID-19, we are seeing unprecedented numbers of Epstein-Barr virus reactivation syndrome. Either stress from the viral infection/vaccine reaction or genomic instability introduced by either provocateur is the cause of the reactivation of […]
Discuss on Nostr!
Nostr Note ID note10xqkh8u08jcsy7lr0jp0yafhk7889um95uz54m4ytq032ndx967qntjl87 Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.